Delivery of imaging agents into brain

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 253-277

  Abbott, N Joan ^a   Chugani, Diane C ^b   Zaharchuk, Greg ^c   Rosen, Bruce R ^c   Lo, Eng H ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; BRAIN; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; DRUG PRODUCTS; GLUCOSE; MAGNETIC RESONANCE IMAGING; METABOLISM; NEUROLOGY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; TISSUE;

BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; IMAGE GLUCOSE TRANSPORT; IMAGING AGENTS; NEUROTRANSMITTER BINDING AND UPTAKE; RADIOPHARMACEUTICALS;

CONTROLLED DRUG DELIVERY;

6 FLUORODOPA F 18; BUTANOL; CARBON 11; CARMUSTINE; CONTRAST MEDIUM; CYCLOLEUCINE; DIAGNOSTIC AGENT; DNA; DYSPROSIUM; FLUMAZENIL; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROMETHANE F 18; GADOLINIUM; GADOLINIUM PENTETATE; IODINE 123; IRON; NEUROTRANSMITTER; NUCLEOTIDE; OXYGEN 15; TECHNETIUM 99M; WATER O 15;

ANATOMY; ARACHNOID; BLOOD BRAIN BARRIER; BLOOD VOLUME; BOLUS INJECTION; BRAIN; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN FUNCTION; BRAIN SCINTISCANNING; CEREBROSPINAL FLUID; CHOROID PLEXUS; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION; DRUG DELIVERY SYSTEM; EPITHELIUM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INTERSTITIAL FLUID; MAGNETISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNIQUE; VASCULAR ENDOTHELIUM;

EID: 0345390143     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00097-0     Document Type: Review

References (156)

1. K. Zeller, S. Rahner-Welsch, W.J. Kuschinsky, Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains, Cerebr. Blood Flow Metabol. 17 (1997) 204-209.
2. H. Davson, M.B. Segal (Eds.), Physiology and Pharmacology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton, 1995.
3. M.L. Upton, R.O. Weller, The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations, J. Neurosurg. 63 (1985) 867-875.
4. N.J. Abbott, M. Bundgaard, H.F. Cserr, Comparative physiology of the blood-brain barrier, in: A.J. Suckling, M.G. Rumsby, M.W.B. Bradbury (Eds.), The Blood-Brain Barrier in Health and Disease. Ellis Horwood, Chichester, 1986, pp. 52-72.
5. M.W. Brightman, Ultrastructure of brain endothelium, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 1-22.
6. J. Gehrmann, Y. Matsumoto, G.W. Kreutzberg, Microglia: intrinsic immuneffector cell of the brain, Brain Res. Rev. 20 (1995) 269-287.
7. H. Wolburg, W. Risau, Formation of the blood-brain barrier, in: H. Kettenmann, B.R. Ransom (Eds.), Neuroglia. Oxford University Press, New York, 1995, pp. 763-776.
8. R.G. Frederickson, F.N. Low, Blood vessels and tissue spaces associated with the brain of the rat, Am. J. Anat. 125 (1969) 123-146.
9. E.T. Zhang, C.B.E. Inman, R.O. Weller, Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum, J. Anat. 170 (1990) 111-123.
10. R.O. Weller, S. Kida, E.-T. Zhang, Pathways of fluid drainage from the brain-morphological aspects and immunological significance in rat and man, Brain Pathol. 2 (1992) 277-284.
11. A. Peters, S.L. Palay, H. de F. Webster, The Fine Structure of the Nervous System. WB.Saunders, Philadelphia, 1991.
12. A. Van Harreveld, The extracellular space in the vertebrate central nervous system, in: G.H. Bourne (Ed.), The Structure and Function of Nervous Tissue, Academic Press, New York, 1972, pp. 447-511.
13. C. Nicholson, E. Sykova, Extracellular space structure revealed by diffusion analysis, Trends Neurosci. 21 (1998) 207-215.
14. L. Tao, C. Nicholson, Diffusion of albumins in rat cortical slices and relevance to volume transmission, Neurosci. 75 (1996) 839-847.
15. H.F. Cserr, C.S. Patlak, Secretion and bulk flow of interstitial fluid, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 245-261.
16. G.P. Shielke, A.L. Betz, Electrolyte transport, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 221-243.
17. M.L. Rennels, T.I. Gregory, O.R. Baumanis, I.C. Fujimoto, RA. Grady, Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space, Brain Res. 326 (1985) 47-63.
18. N.J. Abbott, I.A. Romero, Transporting therapeutics across the blood-brain barrier, Mol. Med. Today 2 (1996) 106-113.
19. Q.R. Smith, Methods of study, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 23-52.
20. A.M. Butt, H.C. Jones, N.J. Abbott, Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study, J. Physiol. 429 (1990) 47-62.
21. E.W. Willoughby, E. Grochowski, D.K.B. Li, J. Oger, L.F. Kastrukoff, D.W. Paty, Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients, Ann. Neurol. 25 (1989) 43-49.
22. A.G. Kermode, A.J. Thompson, P.S. Tofts, et al., Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenic and clinical implications, Brain 113 (1990) 1470-1489.
23. A.J. Thompson, D. Miller, B. Youl, et al., Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration, Neurology 42 (1992) 60-63.
24. C. Guerin, J. Laterra, R.H. Hruban, H. Brem, L.R. Drewes, G.W. Goldstein, The glucose transporter and blood-brain barrier of human brain tumors, Ann. Neurol. 28 (1990) 758-765.
25. M.K. Sharief, E.J. Thompson, In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis, J. Neuroimmunol. 38 (1992) 27-33.
26. R.A. Berkman, M.J. Merrill, W.C. Reinhold, et al., Expression of vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms, J. Clin. Invest. 91 (1993) 153-159.
27. D. Barnes, Clinical assessment of blood-brain barrier permeability: magnetic resonance imaging, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood Brain Barrier. Springer, Berlin, 1992, pp. 301-312.
28. R.A. Kroll, E.A. Neuwelt, Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means, Neurosurgery 42 (1998) 1083-1099.
29. E.A. Neuwelt, L.L. Muldoon, M.A. Pagel, S. Roman-Goldstein, R.A. Kroll, Demonstration of a physiologic barrier distal to the anatomic blood-brain barrier, Neurology 50 (1998) 5021.
30. I. Tamai, A. Tsuji, Drug delivery through the blood-brain barrier, Adv. Drug Delivery Rev. 19 (1996) 401-424.
31. D.J. Brooks, Clinical assessment of the blood-brain barrier: positron emission tomography, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 313-325.
32. L. Farde, The advantage of using positron emission tomography in drug research, Trends Neurosci. 19 (1996) 211-214.
33. P. Luthert, Opening of the barrier in cerebral pathology, in: M.W.B. Bradbury (Ed.), Physiology and Pharmacology of the Blood-Brain Barrier. Springer, Berlin, 1992, pp. 439-457.
34. L. Axel, Cerebral blood flow determination by rapid-sequence computed tomography: A theoretical analysis, Radiology 137 (1980) 679-686.
35. L. Axel, Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique, Invest. Radiol. 18 (1983) 94-99.
36. A. Villringer, B.R. Rosen, J.W. Belliveau, et al., Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects, Magn. Reson. Med. 6 (1988) 164-174.
37. B.R. Rosen, J.W. Belliveau, D. Chien, Perfusion imaging by nuclear magnetic resonance, Magn. Reson. Q. 5 (1989) 263-281.
38. B.R. Rosen, J.W. Belliveau, J.M. Vevea, T.J. Brady, Perfusion imaging with NMR contrast agents, Magn. Reson. Med. 14 (1990) 249-265.
39. Stewart, Researches on the circulation time in organs and on the influences which affect it. Parts I-III. J. Physiol. (London) 15 (1894) 1.
40. N.A. Lassen, Cerebral blood flow and oxygen consumption in man, Physiol. Rev. 39 (1959) 183.
41. K.L. Zierler, Theoretical basis of indicator-dilution methods for measuring flow and volume, Circ. Res. 10 (1962) 393-407.
42. F. Wittlich, K. Kohno, G. Mies, D.G. Norris, M. Hoehn-Berlage, Quantitative measurement of regional blood flow with Gd-DTPA bolus track NMR imaging in cerebral infarcts in rats: Validation with the iodo-14C-antipyrine technique, Proc. Natl. Acad. Sci. USA 92 (1995) 1846-1850.
43. R. Weisskoff, D. Chesler, J. Boxerman, B. Rosen, Pitfalls in MR measurements of tissue blood flow with intravascular tracers: which mean transit time? Magn. Reson. Med. 29 (1993) 553-559.
44. Hamberg, G.J. Hunter, E.F. Halpern, B. Hoop, G.S. Gazelle, G.L. Wolf, Quantitative, high-resolution measurement of cerebral vascular physiology with slip-ring CT. Am. J. Neuroradiol. 17 (1996) 639-650.
45. Hamberg, G.J. Hunter, D. Kierstead, E.H. Lo, R.G. Gonzalez, G.L. Wolf, Measurement of cerebral blood volume with subtraction 3D functional CT. Am. J. Neuroradiol. 17 (1996) 1861-1869.
46. G.J. Hunter, L.M. Hamberg, J.A. Ponzo, et al., Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with 3D functional CT: early clinical results, Am. J. Neuroradiol. 19 (1998) 29-37.
47. B.R. Rosen, J.W. Belliveau, B.R. Buchbinder, et al., Contrast agents and cerebral hemodynamics, Magn. Reson. Med. 19 (1991) 285-292.
48. S. Majumdar, S.S. Zoghbi, J.C. Gore, Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents, Magn. Reson. Imag. 6 (1988) 611-615.
49. J. Boxerman, L. Hamberg, B. Rosen, R. Weisskoff, MR contrast due to intravascular magnetic susceptibility perturbations, Magn. Reson. Med. 34 (1995) 555-566.
50. Lauffer, W. Greif, D. Stark, A. Vincent, V. Wedeen, T. Brady, Iron-EHPG as an hepatobiliary contrast agent: initial imaging and biodistribution studies. J. Comput. Assist. Tomogr. 9 (1985) 431-438.
51. C.R. Fisel, J.L. Ackerman, R.B. Buxton, et al., MR contrast due to microscopically heterogeneous magnetic susceptibility: Numerical simulations and applications to cerebral physiology, Magn. Reson. Med. 17 (1991) 336-347.
52. B.E. Hoppel, R.M. Weisskoff, K.R. Thulborn, J.B. Moore, K.K. Kwong, B.R. Rosen, Measurement of regional blood oxygenation and cerebral hemodynamics, Magn. Reson. Med. 30 (1993) 715-723.
53. R. Weisskoff, C. Zuo, J. Boxerman, B. Rosen, Microscopic susceptibility variation and transverse relaxation: theory and experiment, Magn. Reson. Med. 31 (1994) 601-610.
54. J.L. Boxerman, B.R. Rosen, R.M. Weisskoff, Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies, J. Magn. Reson. Imag. 7 (1997) 528-537.
55. J.W. Belliveau, B.R. Rosen, H.L. Kantor, et al., Functional cerebral imaging by susceptibility-contrast NMR, Magn. Reson. Med. 14 (1990) 538-546.
56. S. Ogawa, T.M. Lee, A.S. Nayak, P. Glynn, Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields, Magn. Reson. Med. 14 (1990) 68-78.
57. 17O, Magn. Reson. Med. 22 (1991) 154-158.
58. B.R. Rosen, J.W. Belliveau, J.A. Fordham, The role of dynamic magnetic resonance imaging in the assessment of stroke, Stroke 2 (1992) 559-576.
59. A. Sorensen, F. Buonanno, R. Gonzalez, et al., Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging, Radiology 199 (1996) 391-401.
60. P.R. Bullock, P. Mansfield, P. Gowland, B.S. Worthington, J.L. Firth, Dynamic imaging of contrast enhancement in brain tumors, Magn. Reson. Med. 19 (1991) 293-298.
61. N.A. Lassen, Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow, J. Cereb. Blood Flow Metabol. 4 (1984) 633-634.
62. R. Weisskoff, L. Porrka, G. Hunter, B. Rosen, Determination of arterial input function: novel contrast mechanism in spin echo images, in Proc. Soc. Magn. Reson. Med., New York, NY, 1991, p. 781.
63. K.A. Rempp, G. Brix, F. Wenz, C.R. Becker, F. Guckel, W.J. Lorenz, Quantitation of cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging, Radiology 193 (1994) 637-641.
64. L. Østergaard, R.M. Weisskoff, D.A. Chesler, C. Glydensted, B.R. Rosen, High resolution measurement of cerebral blood flow using intravascular tracer passages. Part I: Mathematical approach and statistical analysis. Magn. Reson. Med. 36 (1996) 715-725.
65. L. Østergaard, A.G. Sorensen, K.K. Kwong, R.M. Weisskoff, C. Gyldensted, B.R. Rosen, High resolution measurement of cerebral blood flow using intravascular tracers passages. Part II: Experimental comparison and preliminary results, Magn. Reson. Med. 36 (1996) 726-736.
66. L. Østergaard, D.F. Smith, P. Vestergaard-Poulsen, S.B. Hansen, A.D. Gee, A. Gjedde, C. Gyldensted, Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values, J. Cereb. Blood Flow Metabol. 18 (1998) 425-432.
67. W.H. Freygang, L. Sokoloff, Quantitative measurement of regional circulation in the CNS by use of radioactive inert gas, Adv. Biol. Med. Phys. 6 (1958) 263-289.
68. J.C. Baron, R. Frackowiak, K. Herholz, T. Jones, A.A. Lammertsma, B. Mazoyer, K. Weinhard, Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease, J. Cereb. Blood Flow Metabol. 9 (1989) 723-741.
69. K.M. Donahue, D. Burstein, W.J. Manning, M.L. Gray, Studies of Gd-DTPA relaxivity and proton exchange rates in tissue, Magn. Reson. Med. 32 (1994) 66-76.
70. K.M. Donahue, R.M. Weisskoff, D.A. Chesler, K.K. Kwong, A.A. Bogdanov Jr., J.B. Mandeville, B.R. Rosen, Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange, Magn. Reson. Med. 36 (1996) 858-867.
71. R. Lauffer, W. Greif, D. Stark, A. Vincent, V. Wedeen, T. Brady, Iron-EHPG as an hepatobiliary contrast agent: initial imaging and biodistribution studies, J. Comput. Assist. Tomogr. 9 (1985) 431-438.
72. R. Weissleder, G. Elizondo, K. Wittenberg, Ultrasmall superparamagnetic iron oxide. Characterization of a new class of contrast agents for MR imaging, Radiology 175 (1990) 489-493.
73. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov, T. Brady, Monocrystalline iron oxide nanocompounds (MION): physiochemical properties, Magn. Reson. Med. 29 (1993) 599-604.
74. R. Lauffer, T. Brady, Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates, Magn. Reson. Imag. 3 (1985) 11-16.
75. A.A. Bogdanov Jr., R. Weissleder, H.W. Frank, et al., A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies, Radiology 187 (1993) 701-706.
76. L.M. Hamberg, P. Boccalini, G. Stranjalis, et al., Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility contrast MRI, Magn. Reson. Med. 35 (1996) 168-173.
77. J.B. Mandeville, J.J.A. Marota, B.E. Kosofsky, J.R. Keltner, R. Weissleder, B.R. Rosen, R.M. Weisskoff, Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation, Magn. Reson. Med. 39 (1998) 615-624.
78. W. Lin, R.P. Paczynski, K. Kuppusamy, S.Y. Hsu, E.M. Haacke, Quantitative measurements of regional cerebral blood volume using MRI in rats: effects of arterial carbon dioxide tension and mannitol, Magn. Reson. Med. 38 (1997) 420-428.
79. G. Zaharchuk, A.A. Bogdanov Jr., J.J.A. Marota, et al., Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): a steady-state contrast agent techniques for measuring blood flow, relative blood volume fraction, and the water extraction fraction, Magn. Reson. Med. 40 (1998) 666-678.
80. 2H NMR imaging, Magn. Res. Med. 14 (1990) 389-395.
81. K. Kwong, J. Belliveau, D. Chesler, et al., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation, Proc. Natl. Acad. Sci. USA 89 (1992) 5675-5679.
82. J.A. Detre, J.S. Leigh, D.S. Williams, A.P. Koretsky, Perfusion imaging, Magn. Reson. Med. 23 (1992) 37-45.
83. D.S. Williams, J.A. Detre, J.S. Leigh, A.P. Koretsky, Magnetic resonance imaging of perfusion using spin inversion of arterial water [published erratum appears in PNAS USA 1992 May 1; 89(9): 4220], Proc. Natl. Acad. Sci. USA 89 (1992) 212-216.
84. A.C. Silva, W. Zhang, D.S. Williams, A.P. Koretsky, Multislice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labelling, Magn. Reson. Med. 33 (1995) 209-214.
85. G. Zaharchuk, P.J. Ledden, K.K. Kwong, B.R. Rosen, Multislice arterial spin labeling measurements of perfusion territory and functional activation in humans using two coils, in Proc., International Society of Magnetic Resonance in Medicine (ISMRM), Vancouver, BC, 1997, p. 79.
86. D.C. Alsop, L. Maccotta, J.A. Detre, Multi-slice perfusion imaging using adiabatic arterial spin labeling and an amplitude modulated control, in Proc., International Society of Magnetic Resonance in Medicine (ISMRM), New York, NY, 1997, p. 81.
87. E.C. Wong, R.B. Buxton, L.R. Frank, Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling, NMR Biomed. 10 (1997) 237-249.
88. D.A. Roberts, L. Bolinger, J.A. Detre, E.K. Insko, P. Bergey, J.S. Leigh, Continuous inversion angiography, Magn. Reson. Med. 29 (1993) 631-636.
89. K.K. Kwong, D.A. Chesler, R.M. Weisskoff, et al., MR perfusion studies with T1 weighted echo planar imaging, Magn. Reson. Med. 34 (1995) 878-887.
90. S.G. Kim, Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping, Magn. Reson. Med. 34 (1995) 293-301.
91. R. Buxton, L. Frank, B. Siewart, S. Warach, E. Wong, R. Edelman, Quantitative perfusion imaging with EPISTAR. Magn. Reson. Med. in press (1996).
92. R. Edelman, B. Siewart, D. Darby, V. Thangaraj, A. Nobre, M. Mesulam, S. Warach, Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency, Radiology 192 (1994) 513-520.
93. E.C. Wong, R.B. Buxton, L.R. Frank LR, Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II), Magn. Reson. Med. 39 (1998) 702-708.
94. A.J. Wilson, M.R. Sage, The blood-brain barrier and its relation to CT, MR, and nuclear medicine, Imaging 4 (1992) 185-197.
95. V.M. Runge, J.E. Kirsch, J.W. Wells, J.N. Dunworth, M.H. Awh, D.F. Bittner, Magnetic resonance contrast agents in neuroimaging, Neuroimaging Clin North Am 4 (1994) 175-183.
96. A.J. Fischman, J.W. Babich, E.H. Lo, Neuroreceptor imaging in health and disease. In V.P. Torchilin, Handbook of targeted delivery of imaging agents, CRC Press, Boca Raton, 1995, pp. 553-573.
97. W.T.C. Yuh, D.J. Fisher, H.D. Nguyen, E.T. Tali, N.A. Mayr, Application of contrast agents in the evaluation of neoplasms of the central nervous system, Top. Magn. Reson. Imaging 4 (1992) 1-22.
98. W.T.C. Yuh, J.D. Engelken, M.G. Muhonen, N.A. Mayr, D.J. Fisher, J.C. Ehrhadt, Experience with high dose gadolinium MRI in evaluation of brain metastases, Am. J. Neuroradiol. 13 (1992) 335-341.
99. H.J. Aronen, I.E. Gazit, D.N. Louis, et al., Functional imagoing of gliomas using susceptibility contrast CBV mapping: a comparison with tumor grade and histology, Radiology 191 (1994) 41-51.
100. P.E. Valk, T.F. Budinger, V.A. Levin, P. Silver, P.H. Gutin, W.K. Doyle, PET of malignant cerebral tumors after interstitial brachytherapy, J. Neurosurg. 69 (1988) 830-838.
101. K.T. Kim, K.L. Black, D. Marciano, Thallium SPECT imaging of brain tumors: methods and results, J. Nucl. Med. 31 (1990) 965-972.
102. R.B. Schwartz, P.A. Carvalho, E. Alexander, J.S. Loefller, R. Folkerth, B.L. Holman, Radiation necrosis vs high grade recurrent glioma: differentiation by using dual isotope SPECT with 201 T1 and 99m Tc-HMPAO, Am. J. Roentgen. 158 (1992) 399-404.
103. A.D. Elster, Magnetic resonance contrast enhancement in cerebral infarction, Neuroimag. Clin. North Am. 4 (1994) 89-100.
104. E.H. Lo, Y. Pan, K. Matsumoto, N.W. Kowall, Blood-brain barrier disruption in experimental focal ischemia: comparison between in vivo MRI and immunocytochemistry, Magn. Res. Imaging 12 (1994) 403-411.
105. V.M. Runge, J.E. Kirsch, J.W. Wells, J.N. Dunworth, C.E. Woolfolk, Visualization of blood-brain barrier disruption on MR images in cats with acute cerebral infarction, Am. J. Roentgen. 162 (1993) 431-435.
106. M.S. Cohen, R.M. Weisskoff, Ultrafast imaging, Magn. Reson. Imaging 9 (1991) 1-37.
107. P.S. Tofts, B.A. Berkowitz, Measurement of capillary permeability from the gadolinium enhancement curve, Magn. Reson. Imaging 12 (1994) 81-91.
108. C.P. Hawkins, P.M.G. Munro, F. MacKenzie, et al., Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium DTPA and protein markers, Brain 113 (1990) 365-378.
109. S.P. Morrissey, H. Stodal, U. Zettl, et al., In vivo MRI and its histological correlates in acute adoptive transfer EAE: quantification of inflammation and edema, Brain 119 (1996) 239-248.
110. C. Schwarzbauer, S.P. Morrisey, R. Deichman, et al., Quantitative magnetic resonance imaging of capillary water permeability and regional blood volume with an intravascular MR contrast agent, Magn. Reson. Med. 37 (1997) 769-777.
111. V.S. Trubestkoy, V.P. Torchilin, Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents, Adv. Drug Delivery Rev. 16 (1995) 311-320.
112. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anaesthetized albino rat, J. Neurochem. 28 (1977) 897-916.
113. M. Diksic, S. Nagahiro, T.L. Sourkes, Y.L. Yamamoto, A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model, J. Cereb. Blood Flow Metabol. 9 (1990) 1-12.
114. B.K. Madras, T.L. Sourkes, Metabolism of α-methyltryptophan, Biochem. Pharmacol. 14 (1965) 1499-1506.
115. H.T. Chugani, M.E. Phelps, J.C. Mazziotta, Positron emission tomography study of human brain functional development, Ann. Neurol. 22 (1987) 487-497.
116. D.E. Kuhl, E.J. Metter, W.H. Riege, R.A. Hawkins, The effect of normal aging on patterns of local cerebral glucose utilization, Ann. Neurol. 15 (1984) S133-137.
117. T.R. Henry, H.T. Chugani, B.W. Abou-Khalil et al., Positron emission tomography, in: J. Engel Jr. (Ed.), Surgical treatment of the epilepsies, 2nd ed. New York, Raven Press, 1993a, pp. 211-243.
118. S.C. Huang, D.C. Yu, J.R. Barrio, et al., Kinetics and modeling of L-6[18F]fluoro-DOPA in human positron emission tomographic studies, J. Cereb. Blood Flow Metabol. 11 (1991) 898-913.
119. F.J. Vingerhoets, M. Schulzer, T.J. Ruth, J.E. Holden, B.J. Snow, Reproducibility and discriminationg ability of fluorine-18-6-fluoro-L-dopa PET in parkinson's disease, J. Nucl. Med. 37 (1996) 421-426.
120. O. Muzik, D.C. Chugani, P. Chakraborty, T. Mangner, H.T. Chugani, Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo, J. Cereb. Blood Flow and Metabol. 17 (1997) 659-669.
121. S. Nishizawa, C. Benkelfat, S.N. Young, et al., Differences between males and females in rates of serotonin synthesis in human brain, Proc. Natl. Acad. Sci. USA 94 (1997) 5308-5313.
122. D.C. Chugani, O. Muzik, P.K. Chakraborty, T.J. Mangner, H.T. Chugani, Human brain serotonin synthesis capacity measured in vivo with alpha[C-11]methyl-tryptophan, Synapse 28 (1998) 33-43.
123. D.C. Chugani, O. Muzik, R. Rothermel, et al., Altered serotonin synthesis in the dentatothalamo-cortical pathway in autistic boys, Ann. Neurol. 14 (1997) 666-669.
124. D.C. Chugani, E.A. da Silva, O. Muzik, P.K. Chakraborty, T.J. Mangner, H.T. Chugani, Abnormal serotonin synthesis in epileptic foci of children: an in vivo study with alpha[C-11]methyl-tryptophan and positron emission tomography, Epilepsia 38(3) (1997) 45.
125. D.C. Chugani, H.T. Chugani, O. Muzik, J.R. Shah, A.K. Shah, A.I. Canady, T.J. Mangner, P.K. Chakraborty, Imaging epileptogenic tubers in children with tuberous sclerosis complex using α[11C]-methyl-L-tryptophan PET. Ann. Neurol. (in press).
126. D. Louw, G.B. Sutherland, G.B. Glavin, J. Girvin, A study of monoamine metabolism in human epilepsy, Canadian J. Neurol. Sci. 16 (1989) 394-397.
127. M. Pintor, I.N. Mefford, I. Hutter, The level of biogenic amines, their metabolites and tyrosine hydroxylase in the human epileptic temporal cortex, Synapse 5 (1990) 152-156.
128. S. Trottier, B. Evrard, J.P. Vignal, J.M. Scarabin, P. Chauvel, The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia, Epilepsy Res. 25 (1996) 79-106.
129. M.R. Kilbourn, In vivo radiotracers for vesicular neurotransmitter transporters, Nuc. Med. Biol. 24 (1997) 615-619.
130. D.F. Wong, H.N. Wagner, R.F. Dannals, et al., Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain, Science 226 (1984) 1393-1396.
131. L. Farde, E. Ehrin, L. Eriksson, et al., Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography, Proc. Natl. Acad. Sci. USA. 82 (1985) 3863-3867.
132. T.R. Henry, K.A. Frey, J.C. Sackellares, et al., In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy, Neurology 43 (1993) 1998-2006.
133. I. Savic, A. Persson, P. Roland, S. Pauli, G. Sedvall, L. Widen, In vivo demonstraton of reduced benzodiazepine receptor binding in human epileptic foci, Lancet 2 (1988) 863-866.
134. Q.R. Smith, S. Monna, M. Aoyagi, S.I. Rapoport, Kinetics of neutral amino acid transport across the blood-brain barrier, J. Neurochem. 49 (1987) 1651-1658.
135. R.A. Hawkins, S.C. Huang, J.R. Barrio, et al., Estimation of local cerebral protein synthesis rates with 1[C-11]leucine and PET: methods, model and results in animals and humans, J. Cereb. Blood Flow Metabol. 9 (1989) 446-460.
136. A.F. Shields, J.R. Grierson, S.M. Kozawa, M. Zheng, Development of labeled thymidine analogs for imaging tumor proliferation, Nucl. Med. Biol. 23 (1996) 17-22.
137. T. Vander Borght, S. Pauwels, L. Lambotte, D. Labar, S. De Maeght, G. Stroobandt, C. Laterre, Brain tumor imaging with PET and 2-[carbon-11]thymidine, J. Nucl. Med. 35 (1994) 974-982.
138. P. Goethals, M. van Eijkeren, W. Lodewyck, R. Dams, Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors, J. Nucl. Med. 36 (1995) 880-882.
139. S.C. Huang, M.E. Phelps, Principles of tracer kinetic modeling in positron emission tomography and autoradiography, in: M.E. Phelps, J. Mazziotta, Schelbert (Eds.), Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. Raven Press, New York, 1986, pp. 287-346.
140. M. Berman, R. Schoefeld, Invariants in experimental data on linear kinetics and the formulation of models, J. Appl. Physiol. 27 (1956) 1361-1370.
141. R.A. Koeppe, V.A. Holthoff, K.A. Frey, M.R. Kilbourn, D.E. Kuhl, Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography, J. Cereb. Blood Flow Metabol. 11 (1991) 735-744.
142. M.A. Mintun, M.E. Raichle, M.R. Kilbourn, G.F. Wooten, M.J. Welch, A quantitative model for the in vivo assessment of drug binding studies with positron emission tomography, Ann. Neurol. 15 (1984) 217-227.
143. L. Farde, H. Hall, E. Ehrin, G. Sedvall, Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET, Science 231 (1986) 258-261.
144. P. Abadie, J.C. Baron, J.C. Bisserbe, et al., Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography, Eur. J. Pharamcol. 213 (1992) 107-115.
145. J. Delforge, L. Spelle, B. Bendriem, Y. Samson, A. Syrota, Parametric images of benzodiazepine receptor concentration using a partial-saturation injection, J. Cereb. Blood Flow Metabol. 17 (1997) 343-355.
146. J.E. Leyson, W. Gommeren, P.M. Laduron, Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteritics of in vitro binding, Biochem. Pharmacol. 27 (1978) 307-316.
147. P.M. Laduron, P.F.M. Janssen, J.E. Leysen, Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs, Biochem. Pharmacol. 27 (1978) 317-321.
148. I. Creese, Dopamine receptors explained, Trends Neurosci. 5 (1982) 40-43.
149. D.L. Neihoff, J.M. Palacios, M.J. Kuhar, In vivo receptor binding: attempts to improve specific/non-specific ratios. Life Sci. (1979) 819-826.
150. J.K. Saelens, J.P. Simke, S.E. Neale, B.J. Weeks, M. Selwyn, Effects of haloperidol and d-amphetamine on in vivo [H-3] spiroperidol binding in the rat forebrain, Arch. Int. Pharmacodyn. Ther. 246 (1980) 98-107.
151. G. Ellison, W. Morris, Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypes and in vivo spiroperidol accumulation, Eur. J. Pharmacol. 74 (1981) 207-214.
152. D.C. Chugani, R.F. Ackermann, M.E. Phelps, In vivo [H-3]spiperone binding: Evidence for accumulation in corpus striatum by agonist-mediated receptor internalization, J. Cereb. Blood Flow Metabol. 8 (1988) 291-303.
153. M.J. Kopp, H. Hall, A. Persson, G. Sedvall, Temperature dependence of [H-3]Ro15-1788 binding to benzodiazepine receptors in human postmortem brain homogenates, J. Neurochem. 55 (1990) 1310-1315.
154. N.L. Foster, A.F. VanDerSpek, M.S. Aldrich, et al., The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography, J. Cereb. Blood Flow Metabol. 7 (1987) 415-420.
155. J.C. Mazziotta, M.E. Phelps, R.E. Carson, D.E. Kuhl, Tomographic mapping of human cerebral metabolism: auditory stimulation, Neurology 32 (1982) 921-937.
156. P.T. Fox, M.A. Mintun, M.E. Raichle, P. Herscovitch, A noninvasive approach to quantitative functional brain mapping with H2 [15O] and positron emission tomography, J. Cereb. Blood Flow Metabol. 4 (1984) 329-333.